G1 Therapeutics is a biopharmaceutical company focused on the development and commercialization of small molecule therapeutics for the treatment of patients with cancer. It offers COSELA, a product that helps to decrease chemotherapy-induced myelosuppression in adult patients when administered prior to a platinum/etoposide-containing regimen or topotecan-containing regimen for extensive-stage small-cell lung cancer. The company also develops trilaciclib, an intravenous cyclin-dependent kinases (CDK) 4/6 inhibitor for patients with first-line colorectal cancer and neoadjuvant breast cancer. G1 Therapeutics also offers rintodestrant, an oral selective estrogen receptor degrader (SERD) in development for the treatment of estrogen receptor-positive (ER+) breast cancer.
|HQ||Durham, NC, US||Map|
Gross profit (Q1, 2021)
Gross profit margin (Q1, 2021), %
Net income (Q1, 2021)
EBIT (Q1, 2021)
Market capitalization (23-Sept-2021)
Closing stock price (23-Sept-2021)
G1 Therapeutics has 1.21k Twitter Followers. The number of followers has increased 1.3% month over month
Tweets last 30 days
Avg. likes per Tweet
Tweets with engagement
When was G1 Therapeutics founded?
G1 Therapeutics was founded in 2008.
Who are G1 Therapeutics key executives?
G1 Therapeutics's key executives are Mark Avagliano, Jennifer Moses and James Stillman Hanson.
How many employees does G1 Therapeutics have?
G1 Therapeutics has 122 employees.
What is G1 Therapeutics revenue?
Latest G1 Therapeutics annual revenue is $45.3 m.
What is G1 Therapeutics revenue per employee?
Latest G1 Therapeutics revenue per employee is $371.2 k.
Who are G1 Therapeutics competitors?
Competitors of G1 Therapeutics include Kadmon, Zyngenia and Bluebird Bio.
Where is G1 Therapeutics headquarters?
G1 Therapeutics headquarters is located at 400 Park Offices Dr Suite 218, Durham.
Where are G1 Therapeutics offices?
G1 Therapeutics has an office in Durham.
How many offices does G1 Therapeutics have?
G1 Therapeutics has 1 office.
Receive alerts for 300+ data fields across thousands of companies